We’ve witnessed something that feels unusual over the last week. Those large cap stocks that have been so popular for the last three years have...
Garrett Baldwin gives a sneak peek at what's coming for the markets as we draw closer to...
Back in the late 1960s and early 1970s, psychedelics drugs like LSD were still legal and could be researched.
But in 1968 when the federal...
Some market-leading biotech firms are working hard right now developing drugs derived from cannabis' many beneficial compounds.
And there's...
Not every biotech company is doing well in the search for an effective COVID-19 vaccine or treatment.
And the latest firm to struggle is Eli...
The Dow Jones today will plummet as China plans its own tariff hike on $60 billion of U.S. goods starting June 1.
This is the latest...
The tech sector has been having a field day lately, and our Chris Johnson is back with his latest "Best in Breed" focus:...
Investors looking for profits in the healthcare sector had a difficult time in 2017 if they weren't in biotech. The Health Care SPDR ETF only...
Here's a look at the best ETF performers for the week of June 19-23, 2017.
Biotech dominated the list, with four of the top 10...
